GLP1R and alcohol abuse: In a nationwide cohort study in Denmark spanning from 2009 to 2018, researchers investigated the association between GLP-1 agonists and the risk of alcohol-related events, including hospital contacts with a main diagnosis of alcohol use disorders, receiving registered treatments for AUD, or purchase of the benzodiazepine chlordiazepoxide.